DONATE

IBEC project wins funding from the AECC

An IBEC group’s project was granted funding from the Fundación Científica de la Asociación Española Contra el Cáncer in their 2017 Ayudas LAB AECC call.

Nuria Montserrat’s group will work together with researchers from other Barcelona institutes and one of the city’s major hospitals on the project ‘Generation of Isogenic Models of Clear Cell Renal Cell Carcinoma using CRISPR-engineered Kidney Organoids, for the identification of diagnostic biomarkers’. They will receive support over a three-year period from the AECC Scientific Foundation, whose ‘Ayudas LAB’ funds emerging groups to carry out projects in cancer that have obvious translational possibilities.

The project will develop a human model to study clear cell renal cancer, the most common type of kidney cancer. At present, there are no human models for this cancer, nor for the identification of early biomarkers, which would shed light on the molecular mechanisms of how the cancer starts and allow doctors to diagnose it and start treatments earlier.

A material that encourages blood vessels to form

In a further step forward in their quest to achieve functional biomaterials for tissue regeneration, IBEC’s Biomaterials for Regenerative Therapies group has revealed a new construct that enhances blood vessel formation and maturation in vivo.

In the paper published in Acta Biomaterialia at the end of last year, the group and their collaborators at the Georgia Institute of Technology present a new implantable hydrogel that contains both human mesenchymal stromal cells (hMSCs) and calcium-releasing microparticles.

IBEC a key player in FET Flagship proposal

IBEC is on the Steering Committee of a Future Emerging Technologies (FET) Flagship proposal, the Personalised Health Care Initiative in Europe.

The large-scale initiative, if granted, will address the grand challenges of developing regenerative, precision and personalized medicine to improve the quality of life of billions of patients worldwide.

Coordinated from the University of Minho in Portugal, Personalised Health Care has a huge partner and supporter base of more than 125 academia and health institutes, 35 research institutes, 85 industry and associations, and 20 authority representatives. IBEC Director Josep Samitier and group leader Elisabeth Engel are among the 17 members of the steering committee, which includes academics and industry leaders from ten European countries, and the only ones from a partner located in Spain.

Nanomotors can be propelled by light

Researchers working at IBEC and the Max Planck Institute for Intelligent Systems have developed nanomotors that are powered by a fuel-free, biofriendly and unlimited power source: light.

600 attend Bojos per la Ciència opening ceremony

600 people attended the opening ceremony of “Bojos per la Ciència” (Crazy about Science), the Fundació Catalunya-La Pedrera initiative that aims to encourage scientific vocation, at Món Sant Benet on Friday.

2018 will be the first year that IBEC takes part in the initiative, first launched in 2013, which offers courses to selected high school students who show aptitude in science.

IBEC’s course on bioengineering – which has 25 people enrolled – will introduce students to the multidisciplinary environment offered by the field, where different disciplines come together to solve health problems.

How perception shapes our actions

Last Saturday, another “Classico” saw Messi and Ronaldo display their other-worldly skills and ball control. At the heart of their performance stands the amazing ability to control their bodies in anticipation of the movements of their team members, opponents – and especially the football.

These anticipatory motor actions are essential for sport, but also underlie our everyday behavior, from walking or grasping to riding a bicycle or typing on a keyboard. But how exactly are these actions controlled?

Technician Position in Nanomalaria

phdApplication Deadline: 31/01/2018
Ref: TC-XF

The Nanomalaria joint group at the Institute for Bioengineering of Catalonia (IBEC) and the Barcelona Institute for Global Health (ISGlobal) is looking for a Technical position for delivering fluorescently labelled nanocarriers to the mosquito.